Balancing access to ADHD medication.
出版信息
BMC Med. 2023 Jun 19;21(1):217. doi: 10.1186/s12916-023-02917-4.
Abstract
摘要
相似文献
1
Balancing access to ADHD medication.平衡多动症药物的可及性。
BMC Med. 2023 Jun 19;21(1):217. doi: 10.1186/s12916-023-02917-4.
2
Exploring Factors Influencing Medication Adherence From Initiation to Discontinuation in Parents and Adolescents With Attention Deficit Hyperactivity Disorder.探索影响注意力缺陷多动障碍患儿家长及青少年从开始用药到停药期间药物依从性的因素。
Clin Pediatr (Phila). 2020 Mar;59(3):285-296. doi: 10.1177/0009922819900973. Epub 2020 Jan 24.
3
A pilot study of stimulant medication for adults with attention-deficit/hyperactivity disorder (ADHD) who are parents of adolescents with ADHD: the acute effects of stimulant medication on observed parent-adolescent interactions.针对患有注意力缺陷多动障碍（ADHD）的青少年的父母且自身也患有ADHD的成年人进行的兴奋剂药物初步研究：兴奋剂药物对观察到的亲子互动的急性影响。
J Child Adolesc Psychopharmacol. 2014 Dec;24(10):582-5. doi: 10.1089/cap.2014.0092.
4
A qualitative study exploring the decision of parents to use medication in attention-deficit hyperactivity disorder.一项探索父母决定在注意力缺陷多动障碍中使用药物治疗的定性研究。
Res Social Adm Pharm. 2019 Sep;15(9):1095-1101. doi: 10.1016/j.sapharm.2018.11.004. Epub 2018 Nov 10.
5
Caught in a balancing act: parents' dilemmas regarding their ADHD child's treatment with stimulant medication.陷入两难境地：父母在孩子多动症使用兴奋剂药物治疗方面的困境
Qual Health Res. 2006 Nov;16(9):1267-85. doi: 10.1177/1049732306292543.
6
Informed consent and stimulant medication: adolescents' and parents' ability to understand information about benefits and risks of stimulant medication for the treatment of attention-deficit/hyperactivity disorder.知情同意与兴奋剂药物：青少年及家长对治疗注意力缺陷/多动障碍的兴奋剂药物的益处和风险信息的理解能力。
J Child Adolesc Psychopharmacol. 2011 Apr;21(2):139-48. doi: 10.1089/cap.2010.0037.
7
Child and Parental Characteristics of Medication Use for Attention-Deficit/Hyperactivity Disorder.儿童和父母特征与注意缺陷多动障碍药物使用。
J Child Adolesc Psychopharmacol. 2020 Sep;30(7):456-464. doi: 10.1089/cap.2019.0019. Epub 2020 Jul 14.
8
Eliciting preferences for continuing medication among adult patients and parents of children with attention-deficit hyperactivity disorder.成人患者和儿童注意缺陷多动障碍患者父母对继续用药的偏好评估。
Health Expect. 2022 Jun;25(3):1094-1107. doi: 10.1111/hex.13462. Epub 2022 Mar 10.
9
[Factors associated with adherence to pharmacological treatment of attention deficit hyperactivity disorder (ADHD): preliminary review].[与注意缺陷多动障碍（ADHD）药物治疗依从性相关的因素：初步综述]
Medicina (B Aires). 2023 Mar;83 Suppl 2:27-31.
10
Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.在一项关于赖氨酸右旋苯丙胺治疗父母注意力缺陷/多动障碍的随机对照试验中，父母报告的家庭功能改善情况
J Child Adolesc Psychopharmacol. 2017 Apr;27(3):250-257. doi: 10.1089/cap.2016.0129. Epub 2016 Dec 19.
引用本文的文献
1
Telehealth Use in Medicaid: Implications for Quality Care for Individuals With ADHD and Tourette Syndrome.医疗补助计划中的远程医疗使用：对注意力缺陷多动障碍和抽动秽语综合征患者优质护理的影响
Public Health Rep. 2025 Aug 17:333549251357825. doi: 10.1177/00333549251357825.
2
An Open-Label Extension Study Assessing the Long-Term Safety and Efficacy of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.一项评估维洛沙嗪缓释胶囊治疗成人注意缺陷多动障碍的长期安全性和疗效的开放性扩展研究。
CNS Drugs. 2024 Nov;38(11):891-907. doi: 10.1007/s40263-024-01120-0. Epub 2024 Oct 7.
Zotero 插件